Products
Comprehensive catalog of pharmaceutical solutions. Browse categories and send inquiries directly.
All Products (882)
| Molecule | Drug Class / Mechanism | Oncology Type | Inquiry | |
|---|---|---|---|---|
Gemcitabine |
Antimetabolite | Both (Solid & Hematologic) | ||
|
Molecule
Gemcitabine
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
||||
Gimatecan |
Topoisomerase Inhibitor | Both (Solid & Hematologic) | ||
|
Molecule
Gimatecan
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
||||
Giredestrant |
Selective Estrogen Receptor Degrader (SERD) | Solid Tumour (Breast) | ||
|
Molecule
Giredestrant
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Degrader (SERD) |
||||
Glucarpidase |
Cytoprotective / Antidote Agent | Both (Solid & Hematologic) | ||
|
Molecule
Glucarpidase
Therapeutic Category
Supportive Care (Chemoprotective/Rescue Agent)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Cytoprotective / Antidote Agent |
||||
Glufosfamide |
Alkylating Agent | Both (Solid & Hematologic) | ||
|
Molecule
Glufosfamide
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
||||
Granisetron |
5-HT3 Receptor Antagonist | Both (Solid & Hematologic) | ||
|
Molecule
Granisetron
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
||||
Heparin Sodium |
Anticoagulant (Cancer-Associated Thrombosis) | Both (Solid & Hematologic) | ||
|
Molecule
Heparin Sodium
Therapeutic Category
Supportive Care (Anticoagulant)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anticoagulant (Cancer-Associated Thrombosis) |
||||
Heptaplatin |
Platinum Compound | Solid Tumour | ||
|
Molecule
Heptaplatin
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
Platinum Compound |
||||
Histrelin |
LHRH Agonist | Solid Tumour (Prostate/Breast) | ||
|
Molecule
Histrelin
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate/Breast)
Drug Class / Mechanism
LHRH Agonist |
||||
Human Albumin (Transfusion Adjunct) |
Hematinic / Clotting Factor / Plasma Product | Hematologic | ||
|
Molecule
Human Albumin (Transfusion Adjunct)
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
||||
Hydromorphone |
Opioid / Adjuvant Analgesic | Both (Solid & Hematologic) | ||
|
Molecule
Hydromorphone
Therapeutic Category
Supportive Care (Analgesic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Opioid / Adjuvant Analgesic |
||||
Hydroxocobalamin |
Hematinic / Clotting Factor / Plasma Product | Hematologic | ||
|
Molecule
Hydroxocobalamin
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
||||
GemcitabineCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Antimetabolite |
|
GimatecanCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Topoisomerase Inhibitor |
|
GiredestrantHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Breast)
Drug Class / Mechanism
Selective Estrogen Receptor Degrader (SERD) |
|
GlucarpidaseSupportive Care (Chemoprotective/Rescue Agent) |
|
|
Therapeutic Category
Supportive Care (Chemoprotective/Rescue Agent)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Cytoprotective / Antidote Agent |
|
GlufosfamideCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Alkylating Agent |
|
GranisetronSupportive Care (Antiemetic) |
|
|
Therapeutic Category
Supportive Care (Antiemetic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
5-HT3 Receptor Antagonist |
|
Heparin SodiumSupportive Care (Anticoagulant) |
|
|
Therapeutic Category
Supportive Care (Anticoagulant)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Anticoagulant (Cancer-Associated Thrombosis) |
|
HeptaplatinCytotoxic Chemotherapy |
|
|
Therapeutic Category
Cytotoxic Chemotherapy
Oncology Type
Solid Tumour
Drug Class / Mechanism
Platinum Compound |
|
HistrelinHormonal Therapy |
|
|
Therapeutic Category
Hormonal Therapy
Oncology Type
Solid Tumour (Prostate/Breast)
Drug Class / Mechanism
LHRH Agonist |
|
Human Albumin (Transfusion Adjunct)Supportive Care (Hematinic / Coagulation Factor) |
|
|
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
|
HydromorphoneSupportive Care (Analgesic) |
|
|
Therapeutic Category
Supportive Care (Analgesic)
Oncology Type
Both (Solid & Hematologic)
Drug Class / Mechanism
Opioid / Adjuvant Analgesic |
|
HydroxocobalaminSupportive Care (Hematinic / Coagulation Factor) |
|
|
Therapeutic Category
Supportive Care (Hematinic / Coagulation Factor)
Oncology Type
Hematologic
Drug Class / Mechanism
Hematinic / Clotting Factor / Plasma Product |
|